ARTICLE | Clinical News
Tecentriq atezolizumab: Additional Phase II data
June 13, 2016 7:00 AM UTC
Data from a cohort 1 of the open-label, international Phase II IMvigor210 trial in 119 evaluable patients with locally advanced or metastatic urothelial carcinoma in the open-label, international Phas...